Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
Megan N Gower,1 Lindsay R Ratner,1 Alexis K Williams,1 Joseph S Rossi,2 George A Stouffer,2,3 Craig R Lee1,3 1Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA; 2Division of Cardiology, UNC School of Medicine, Chapel Hill, NC, USA; 3UNC...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-07-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-utility-of-cyp2c19-genotype-guided-antiplatelet-therapy-in-pa-peer-reviewed-article-PGPM |